Group One Trading
STAB

Group One Trading’s Statera Biopharma, Inc. Common Stock STAB Stock Holding History

Group One Trading’s Portfolio STAB Stock Details STAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-500
Closed -$1K – 9039
2021
Q4 		$1K Buy
+500
New +$1.48K ﹤0.01% 8083
2014
Q1 		– Sell
-3,040
Closed -$71K – 5690
2013
Q4 		$71K Sell
3,040
-1,240
-29% -$33.7K ﹤0.01% 3332
2013
Q3 		$134K Buy
4,280
+2,775
+184% +$91.8K ﹤0.01% 2754
2013
Q2 		$48K Buy
+1,505
New +$51.8K ﹤0.01% 3469

Other funds holding STAB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
Empery Asset Management New York $83M AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return

Group One Trading's STAB Position: Q2 2019 in Review

Group One Trading sold out of Statera Biopharma, Inc. Common Stock (STAB) in Q2 2019, closing a stake of 68 shares.

Group One Trading first reported a position in STAB in Q2 2013 and held it in 23 quarters. The position peaked at $36K in Q2 2013. 12 funds tracked by Wall St. Rank hold STAB as of Q2 2019.

  • Group One Trading reported no remaining Statera Biopharma, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
  • Group One Trading sold 68 Statera Biopharma, Inc. Common Stock shares in Q2 2019.
  • Group One Trading first reported a position in Statera Biopharma, Inc. Common Stock in Q2 2013 and held it in 23 quarters.
  • Group One Trading's Statera Biopharma, Inc. Common Stock position peaked at $36K in Q2 2013.
  • 12 funds tracked by Wall St. Rank held Statera Biopharma, Inc. Common Stock as of Q2 2019.

Based on Group One Trading's 13F filing for Q2 2019, filed 9 Aug 2019.